Predicting human microbe–drug associations via graph convolutional network with conditional random field

Author:

Long Yahui12,Wu Min3ORCID,Kwoh Chee Keong2,Luo Jiawei1,Li Xiaoli3

Affiliation:

1. College of Computer Science and Electronic Engineering, Hunan University, Changsha 410000, China

2. School of Computer Science and Engineering, Nanyang Technological University, Singapore 639798, Singapore

3. Machine Intellection Department, Institute for Infocomm Research, Agency for Science, Technology and Research (A*STAR), Singapore 138632, Singapore

Abstract

Abstract Motivation Human microbes play critical roles in drug development and precision medicine. How to systematically understand the complex interaction mechanism between human microbes and drugs remains a challenge nowadays. Identifying microbe–drug associations can not only provide great insights into understanding the mechanism, but also boost the development of drug discovery and repurposing. Considering the high cost and risk of biological experiments, the computational approach is an alternative choice. However, at present, few computational approaches have been developed to tackle this task. Results In this work, we leveraged rich biological information to construct a heterogeneous network for drugs and microbes, including a microbe similarity network, a drug similarity network and a microbe–drug interaction network. We then proposed a novel graph convolutional network (GCN)-based framework for predicting human Microbe–Drug Associations, named GCNMDA. In the hidden layer of GCN, we further exploited the Conditional Random Field (CRF), which can ensure that similar nodes (i.e. microbes or drugs) have similar representations. To more accurately aggregate representations of neighborhoods, an attention mechanism was designed in the CRF layer. Moreover, we performed a random walk with restart-based scheme on both drug and microbe similarity networks to learn valuable features for drugs and microbes, respectively. Experimental results on three different datasets showed that our GCNMDA model consistently achieved better performance than seven state-of-the-art methods. Case studies for three microbes including SARS-CoV-2 and two antimicrobial drugs (i.e. Ciprofloxacin and Moxifloxacin) further confirmed the effectiveness of GCNMDA in identifying potential microbe–drug associations. Availability and implementation Python codes and dataset are available at: https://github.com/longyahui/GCNMDA. Supplementary information Supplementary data are available at Bioinformatics online.

Funder

National Natural Science Foundation of China

Chinese Scholarship Council

Publisher

Oxford University Press (OUP)

Subject

Computational Mathematics,Computational Theory and Mathematics,Computer Science Applications,Molecular Biology,Biochemistry,Statistics and Probability

Reference65 articles.

1. Isolation and characterization of small qnrs1-carrying plasmids from imported seafood isolates of Salmonella enterica that are highly similar to plasmids of clinical isolates;Akiyama;FEMS Immunol. Med. Microbiol,2012

2. Discovery and development of safe-in-man broad-spectrum antiviral agents;Andersen;Int. J. Infect. Dis,2020

3. Moxifloxacin;Balfour;Drugs,1999

4. Conjunctival microflora and its antibiotic sensitivity after serial intravitreal injections;Budzinskaya;Vestnik Oftalmologii,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3